Pancreatic cancer MRI

Pancreatic cancer Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Pancreatic Cancer from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic study of choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Pancreatic cancer MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Pancreatic cancer MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Pancreatic cancer MRI
CDC on Pancreatic cancer MRI
Pancreatic cancer MRI in the news
Blogs on Pancreatic cancer MRI
Directions to Hospitals Treating Pancreatic cancer
Risk calculators and risk factors for Pancreatic cancer MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]Faizan Sheraz, M.D. [3]

Overview

On abdominal MRI, pancreatic cancer appears as hypointense with slower enhancement than normal pancreatic tissue.

MRI

Signal characteristics include:

• T1: hypo intense c.f. normal pancreas
• T1 FS: hypo intense c.f. normal pancreas
• T1 + C (Gd): slower enhancement than normal pancreas, therefore dynamic injection with arterial phase imaging with fat saturation is ideal
• T2/FLAIR: variable (therefore not very useful) depending on the amount of reactive desmoplastic reaction